[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kajander et al., 2005 - Google Patents

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6‐month intervention

Kajander et al., 2005

View PDF
Document ID
11311766072760636847
Author
Kajander K
Hatakka K
Poussa T
Färkkilä M
Korpela R
Publication year
Publication venue
Alimentary pharmacology & therapeutics

External Links

Snippet

Background: Irritable bowel syndrome is a gastrointestinal disorder of unknown aetiology. The effect of probiotics in this syndrome remains unclear. Aim: To investigate whether a probiotic mixture containing Lactobacillus rhamnosus GG, L. rhamnosus LC705 …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using micro-organisms or enzymes using only micro-organisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens

Similar Documents

Publication Publication Date Title
Kajander et al. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6‐month intervention
Riezzo et al. Randomised clinical trial: efficacy of Lactobacillus paracasei‐enriched artichokes in the treatment of patients with functional constipation–a double‐blind, controlled, crossover study
Majeed et al. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study
Williams et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double‐blind placebo‐controlled study
Almeida et al. Beneficial effects of long‐term consumption of a probiotic combination of Lactobacillus casei Shirota and Bifidobacterium breve Yakult may persist after suspension of therapy in lactose‐intolerant patients
Masoumi et al. The effect of yogurt fortified with Lactobacillus acidophilus and Bifidobacterium sp. probiotic in patients with lactose intolerance
Lionetti et al. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature
Simrén et al. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome–a randomized, double‐blind, controlled study
Banaszkiewicz et al. Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial
Enck et al. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo
Anukam et al. Probiotics: 100 years (1907–2007) after Elie Metchnikoff’s observation
Kajander et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota
Kim et al. Effect of diet on the gut microbiota associated with obesity
Vandenplas et al. Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children
De Vrese et al. Probiotics and prebiotics: effects on diarrhea
Floch The role of prebiotics and probiotics in gastrointestinal disease
Veerappan et al. Probiotics for the treatment of inflammatory bowel disease
María Remes-Troche et al. Lactobacillus acidophilus LB: A useful pharmabiotic for the treatment of digestive disorders
Francavilla et al. Randomised clinical trial: L actobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea‐a double‐blind study
Tsuchiya et al. Single‐blind follow‐up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome
Spiller Probiotics and prebiotics in irritable bowel syndrome
Cummings et al. A study of fructo oligosaccharides in the prevention of travellers’ diarrhoea
Dimidi et al. Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation
Mazlyn et al. Effects of a probiotic fermented milk on functional constipation: a randomized, double‐blind, placebo‐controlled study
Weichselbaum Probiotics and health: a review of the evidence